Sato Fumiaki, Tsuchiya Soken, Terasawa Kazuya, Tsujimoto Gozoh
Department of Nanobio Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Kyoto, Japan.
PLoS One. 2009;4(5):e5540. doi: 10.1371/journal.pone.0005540. Epub 2009 May 14.
Over the last decade, DNA microarray technology has provided a great contribution to the life sciences. The MicroArray Quality Control (MAQC) project demonstrated the way to analyze the expression microarray. Recently, microarray technology has been utilized to analyze a comprehensive microRNA expression profiling. Currently, several platforms of microRNA microarray chips are commercially available. Thus, we compared repeatability and comparability of five different microRNA microarray platforms (Agilent, Ambion, Exiqon, Invitrogen and Toray) using 309 microRNAs probes, and the Taqman microRNA system using 142 microRNA probes. This study demonstrated that microRNA microarray has high intra-platform repeatability and comparability to quantitative RT-PCR of microRNA. Among the five platforms, Agilent and Toray array showed relatively better performances than the others. However, the current lineup of commercially available microRNA microarray systems fails to show good inter-platform concordance, probably because of lack of an adequate normalization method and severe divergence in stringency of detection call criteria between different platforms. This study provided the basic information about the performance and the problems specific to the current microRNA microarray systems.
在过去十年中,DNA微阵列技术为生命科学做出了巨大贡献。微阵列质量控制(MAQC)项目展示了分析表达微阵列的方法。最近,微阵列技术已被用于分析全面的微小RNA表达谱。目前,有几种微小RNA微阵列芯片平台可供商业使用。因此,我们使用309个微小RNA探针比较了五种不同微小RNA微阵列平台(安捷伦、安比昂、Exiqon、英杰能和东丽)的重复性和可比性,以及使用142个微小RNA探针的Taqman微小RNA系统。这项研究表明,微小RNA微阵列具有较高的平台内重复性,并且与微小RNA的定量逆转录聚合酶链反应具有可比性。在这五个平台中,安捷伦和东丽阵列表现相对优于其他平台。然而,目前市售的微小RNA微阵列系统未能显示出良好的平台间一致性,这可能是由于缺乏适当的标准化方法以及不同平台之间检测调用标准的严格性存在严重差异。这项研究提供了有关当前微小RNA微阵列系统性能和特定问题的基本信息。